How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018, Weill Cornell Medical College
DNA (green) residing in fluid outside of cells' main nuclei. Credit: Wenjing Wu/Memorial Sloan Kettering Cancer Center/Nature

Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers.

How metastasis occurs has been one of the central mysteries of cancer biology. The findings, published Jan. 17 in Nature, appear to have partly solved this mystery. The authors traced the complex chain of events that results from chromosomal instability - a widespread feature of in which DNA is copied incorrectly every time these divide, resulting in with unequal DNA content. Using models of breast and lung cancer, the investigators found that chromosomal instability leads to changes in the cells that drive metastasis.

"We showed that chromosomal instability can cause a leakage of DNA from the nuclei of cancer cells, leading to a chronic inflammatory response within the cells—and the cells essentially can hijack that response to enable themselves to spread to distant organs," said study lead author Dr. Samuel Bakhoum, a Holman research fellow at Weill Cornell Medicine and a senior resident in radiation oncology at Memorial Sloan Kettering Cancer Center.

The discovery is principally a basic science advance, but should also have long-range implications for cancer drug development.

"Metastasis causes 90 percent of cancer deaths, and this work opens up new possibilities for therapeutically targeting it," said senior author Dr. Lewis Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center and a professor of cancer biology at Weill Cornell Medicine.

Prior studies have linked chromosomal instability to metastasis, although the reason for the link hasn't been clear. "Our starting hypothesis was that chromosomal instability generates a lot of genetically different cells, and that a Darwinian selection process promotes the survival of the cells that are capable of spreading and forming distant tumors," Dr. Bakhoum said.

When he injected chromosomally unstable tumor cells into mice, he indeed found that they were many times more likely to spread and form new tumors than tumor cells in which chromosomal instability was suppressed. That was true even though both sets of tumor cells started out genetically identical, with the same abnormal numbers of chromosomes, suggesting that chromosomal instability itself was a driver of metastasis.

The researchers examined gene activity in these two sets of tumor cells. They found that those with high chromosomal instability had abnormally elevated activity stemming from more than 1,500 genes—particularly in ones involved in inflammation and the response of the immune system to viral infections. "These were cancer cells cultured in a dish, not in the presence of any ," Dr. Bakhoum said. "We were very surprised by that and wondered what could be driving this inflammatory reaction."

Recent studies by other laboratories offered some clues: Chromosomes in unstable tumor cells can sometimes leak out of the cell nucleus where they normally reside. These mis-located chromosomes encapsulate themselves to form "micronuclei" in the fluid, or cytosol, in the main part of the cell outside of the main nucleus. However, micronuclei tend to rupture eventually, releasing naked DNA into the cytosol.

Cells interpret DNA in the cytosol as a sign of an infecting virus, which typically releases its DNA in the cytoplasm when it first attacks a cell. Human cells have evolved to fight this type of viral infection by sensing naked cytosolic DNA using a molecular machine called the cGAS-STING pathway. Once activated, this pathway triggers an inflammatory antiviral program.

Dr. Bakhoum and colleagues examined their chromosomally unstable tumor cells, and found that they did indeed have plenty of cytosolic DNA—and showed evidence of chronic activation of the anti-viral cGAS-STING proteins. Lowering cGAS-STING levels reduced inflammation and prevented the ability of otherwise aggressive tumor cells to metastasize when injected into mice.

In an ordinary cell, an antiviral response stimulated by DNA leakage from the nucleus would soon bring about the cell's death. The researchers found, however, that tumor cells have succeeded in suppressing the lethal elements of the cGAS-STING response. At the same time, they use other parts of the response to enable themselves to detach from the tumor and become mobile within the body.

"They start acting as if they were certain kinds of immune cells, which are normally activated by infection," Dr. Bakhoum said. "In response, they move to the site of infection or injury in the body very quickly. By doing so, cancer cells engage in some form of lethal immune mimicry."

The researchers estimate, based on recent studies of metastatic tumor properties, that about half of human metastases originate this way. They are currently investigating strategies for blocking the process.

It might not be feasible to target itself, since tumor cells are inherently prone to that, Dr. Bakhoum said. However, he noted, "chromosomally unstable , with their cytosolic DNA, are basically full of their own poison." Undoing their ability to suppress normal and lethal antiviral response to cytosolic DNA would, in principle, kill these aggressive cells swiftly, with minimal effects on other cells.

"One of our next steps is to understand better how these cells alter the normal response and how we can restore it," Dr. Bakhoum said.

Explore further: Cancer cells metastasize by hitching a ride on platelets

More information: Samuel F. Bakhoum et al, Chromosomal instability drives metastasis through a cytosolic DNA response, Nature (2018). DOI: 10.1038/nature25432

Related Stories

Cancer cells metastasize by hitching a ride on platelets

September 8, 2016
Metastasis of cancer cells to sites distant from the primary tumor is the leading cause of cancer-related death, and there is growing evidence that platelets aid the dissemination of cancer cells.

MicroRNA helps cancer evade immune system

September 18, 2017
The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor ...

Molecular fingerprint of breast tumors linked to immune response in bloodstream

September 28, 2017
Using newly developed software, researchers have shown that genes and molecular processes in breast cancer tumor cells are tightly linked to genes and processes in blood cells, including immune system cells. The findings ...

Uncovering the mechanisms that support the spread of ovarian cancer

October 10, 2016
A very high mortality rate is associated with ovarian cancer, in part due to difficulties in detecting and diagnosing the disease at early stages before tumors have spread, or metastasized, to other locations in the body.

DNA sensor plays critical role in cancer immunotherapy via response to unexpected DNA form

August 24, 2017
UT Southwestern Medical Center researchers report for the first time that tumors stressed by cancer immunotherapy release their mitochondrial DNA into nearby immune cells, triggering a host alert system.

Scientists find the key to improved cancer immunotherapy

July 18, 2017
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) have investigated how different subtypes of essential immune-response cells called CD8+ T lymphocytes cooperate to mount a stronger ...

Recommended for you

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.